000 | 01739 a2200457 4500 | ||
---|---|---|---|
005 | 20250516171106.0 | ||
264 | 0 | _c20131122 | |
008 | 201311s 0 0 eng d | ||
022 | _a1097-6787 | ||
024 | 7 |
_a10.1016/j.jaad.2013.04.032 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMachet, Laurent | |
245 | 0 | 0 |
_aSystematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseases. _h[electronic resource] |
260 |
_bJournal of the American Academy of Dermatology _cOct 2013 |
||
300 |
_a649-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review; Systematic Review | ||
650 | 0 | 4 |
_aAcquired Hyperostosis Syndrome _xdiagnosis |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
650 | 0 | 4 |
_aColitis, Ulcerative _xdiagnosis |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aCrohn Disease _xdiagnosis |
650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHidradenitis Suppurativa _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xdiagnosis |
650 | 0 | 4 | _aInfliximab |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPsoriasis _xdiagnosis |
650 | 0 | 4 |
_aPyoderma Gangrenosum _xdiagnosis |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdiagnosis |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aSamimi, Mahtab | |
700 | 1 | _aDelage, Maïa | |
700 | 1 | _aPaintaud, Gilles | |
700 | 1 | _aMaruani, Annabel | |
773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 69 _gno. 4 _gp. 649-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaad.2013.04.032 _zAvailable from publisher's website |
999 |
_c23086640 _d23086640 |